Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,

Dongwen Lv(Augusta University Health), Daohong Zhou(The University of Texas at San Antonio Health Science Center)
Nature Communications
November 25, 2021
Cited by 145


Related Papers